Öppna denna publikation i ny flik eller fönster >>2025 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]
Background and aims: Third molar surgery is a common surgical procedure and a well-established pain model in research, which is generally performed under local anaesthesia. Post-operative pain management is often solved with a combination of paracetamol and ibuprofen. In this thesis, our goal was to find a better alternative for pain management in the early post-operative period. The overall aim was to study if preoperative IV S-ketamine (0.125mg/kg or 0.25mg/kg) can offer a more effective and safer transition from local anaesthesia to orally administered analgesia, to investigate whether surgery or S-ketamine have an impact on inflammatory biomarkers in plasma, and to examine differences in protein expression between saliva and plasma.
Patients and methods: 168 patients participated in the study. Physiological variables, questionnaires, pain diaries, and self-reported side effects were all registered in the study. Biomarkers in plasma and saliva were analysed using a multiplex panel (Olink).
Results: There was a globally significant lower pain score in the group with high dose S-ketamine, and a longer time to first rescue medication. There were minor, clinically insignificant changes of SpO2 and pulse rate in the S-ketamine 0.25 mg/kg group. Surgery significantly affected certain biomarkers (IL6, CST5, OSM, TGF-alpha, IL10, FGF-19, Flt3L, white blood cell count, neutrophil blood cell count, cortisol, and high sensitivity c-reactive protein). S-ketamine had no impact on the expression of biomarkers. Although major differences were observed in biomarker expression between saliva and plasma, the correlations were ultimately limited and weak.
Conclusion: A single dose of S-ketamine 0.25 mg/kg IV reduces postoperative pain for up to 24h with a longer time to first rescue medication, compared to S -ketamine 0.125 mg/kg and placebo. Single dose S-ketamine 0.25 mg/kg IV gives a minor reduction of SpO2 and a minor increase of pulse rate at the end of infusion of S-ketamine. These changes are clinically insignificant. Third molar surgery causes an immune response within 2 hours expressed in plasma; infusion of S-ketamine 0.25 or 0.125 mg/kg does not cause any immune reaction. The immune response in saliva vs plasma differs and are not interchangeable.
Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2025. s. 103
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2194
Nyckelord
Pain, Postoperative pain, S-ketamine, Third molar surgery, Efficacy, Safety, Biomarkers, Inflammatory biomarkers, Plasma, Saliva.
Nationell ämneskategori
Anestesi och intensivvård
Identifikatorer
urn:nbn:se:uu:diva-566983 (URN)978-91-513-2621-4 (ISBN)
Disputation
2025-12-03, Bibliotekets föreläsningssal, Falu lasarett, Söderbaums väg 8, Falun, 13:00 (Svenska)
Opponent
Handledare
2025-11-062025-10-092025-11-06